He H - Search Results

1

Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer.

Wang X, He H, Rui W, Xie X, Wang D, Zhu Y. Wang X, et al. Among authors: he h. Onco Targets Ther. 2020 Mar 24;13:2483-2490. doi: 10.2147/OTT.S232965. eCollection 2020. Onco Targets Ther. 2020. PMID: 32273720 Free PMC article.

2

Myxoid adrenocortical adenoma: a case report.

Zhu Y, Wu YX, Zhang CY, Zhao JP, Rui WB, He HC, Shen ZJ. Zhu Y, et al. Chin Med J (Engl). 2008 Aug 20;121(16):1598-600. Chin Med J (Engl). 2008. PMID: 18982876 No abstract available.

3

Heparanase-1 and Cyclooxygenase-2: prognostic indicators of malignancy in pheochromocytomas.

Zhu Y, He HC, Yuan F, Zhang J, Rui WB, Zhao JP, Shen ZJ, Ning G. Zhu Y, et al. Endocrine. 2010 Aug;38(1):93-9. doi: 10.1007/s12020-010-9356-y. Epub 2010 Jun 18. Endocrine. 2010. PMID: 20960108

4

Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma.

Zhu Y, He HC, Su TW, Wu YX, Wang WQ, Zhao JP, Shen Z, Zhang CY, Rui WB, Zhou WL, Sun FK, Ning G. Zhu Y, et al. Endocrine. 2010 Oct;38(2):254-9. doi: 10.1007/s12020-010-9381-x. Epub 2010 Jul 18. Endocrine. 2010. PMID: 21046486 Clinical Trial.

5

Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy.

Xu YZ, Zhu Y, Shen ZJ, Sheng JY, He HC, Ma G, Qi YC, Zhao JP, Wu YX, Rui WB, Wei Q, Zhou WL, Xie X, Ning G. Xu YZ, et al. Endocrine. 2011 Dec;40(3):445-51. doi: 10.1007/s12020-011-9502-1. Epub 2011 Jun 25. Endocrine. 2011. PMID: 21706269

6

Retroperitoneal adrenal-sparing surgery for the treatment of Cushing's syndrome caused by adrenocortical adenoma: 8-year experience with 87 patients.

He HC, Dai J, Shen ZJ, Zhu Y, Sun FK, Shao Y, Zhang RM, Wang HF, Rui WB, Zhong S. He HC, et al. World J Surg. 2012 May;36(5):1182-1188. doi: 10.1007/s00268-012-1509-0. World J Surg. 2012. PMID: 22382766

7

Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence.

Zhao J, Zhu Y, Zhang C, Wang X, He H, Wang H, Wu Y, Zhou W, Shen Z. Zhao J, et al. Among authors: he h. Urol Oncol. 2013 Nov;31(8):1800-5. doi: 10.1016/j.urolonc.2012.04.019. Epub 2012 May 31. Urol Oncol. 2013. PMID: 22658883 Clinical Trial.

8

Ureteroscopic lithotripsy using holmium laser for 187 patients with proximal ureteral stones.

Liu DY, He HC, Wang J, Tang Q, Zhou YF, Wang MW, Chu CL, Zhang CY, Zhu Y, Zhou WL, Shen ZJ. Liu DY, et al. Chin Med J (Engl). 2012 May;125(9):1542-6. Chin Med J (Engl). 2012. PMID: 22800818

9

Myxoid adrenal cortical tumor: report of four cases.

Sheng JY, He HC, Zhu Y, Wu YX, Shen ZJ, Zhao JP, Ma G, Xu YZ. Sheng JY, et al. Chin Med J (Engl). 2012 May;125(9):1672-4. Chin Med J (Engl). 2012. PMID: 22800844 Review.

10

Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cm.

Fang C, Xie X, Xu T, He W, He H, Wang X, Zhu Y, Shen Z, Shao Y. Fang C, et al. Among authors: he w, he h. Int Urol Nephrol. 2017 Jul;49(7):1177-1182. doi: 10.1007/s11255-017-1576-0. Epub 2017 Mar 25. Int Urol Nephrol. 2017. PMID: 28343326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,862 results

Search Page

Filters